ConductScience.org, home

Trial · NCT01111838

Adverse events51

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherALT, SGPTBlood and lymphatic system disordersPatients With Refractory Metastatic Colorectal Cancer7157
otherAST, SGOTBlood and lymphatic system disordersPatients With Refractory Metastatic Colorectal Cancer9159
otherAlbumin, low (hypoalbuminemia)Metabolism and nutrition disordersPatients With Refractory Metastatic Colorectal Cancer6156
otherAlkaline phosphataseMetabolism and nutrition disordersPatients With Refractory Metastatic Colorectal Cancer101510
otherAllergy reaction (including drug fever)General disordersPatients With Refractory Metastatic Colorectal Cancer1152
otherAmylaseBlood and lymphatic system disordersPatients With Refractory Metastatic Colorectal Cancer4154
otherAnorexiaPsychiatric disordersPatients With Refractory Metastatic Colorectal Cancer3154
otherAscites (non-malignant)General disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherBilirubin (hyperbilirubinemia)Metabolism and nutrition disordersPatients With Refractory Metastatic Colorectal Cancer6156
otherCPK (creatine phosphokinase)Metabolism and nutrition disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherConstitutional SymptomsGeneral disordersPatients With Refractory Metastatic Colorectal Cancer2152
otherDental: dentures or prosthesisMusculoskeletal and connective tissue disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherDiarrheaGastrointestinal disordersPatients With Refractory Metastatic Colorectal Cancer91514
otherDistension/bloating, abdominalGastrointestinal disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherDizzinessNervous system disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherDyspnea (shortness of breath)Respiratory, thoracic and mediastinal disordersPatients With Refractory Metastatic Colorectal Cancer2152
otherFatigue (asthenia, lethargy, malaise)General disordersPatients With Refractory Metastatic Colorectal Cancer91512
otherFever (in the absence of neutropenia)General disordersPatients With Refractory Metastatic Colorectal Cancer2152
otherGastrointestinal, otherGastrointestinal disordersPatients With Refractory Metastatic Colorectal Cancer1151
otherGlucose, high (hyperglycemia)Metabolism and nutrition disordersPatients With Refractory Metastatic Colorectal Cancer7157

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01111838/events